Calliditas Therapeutics AB ADR (CALT)

Calliditas Therapeutics AB ADR (CALT) 最新ニュース

Calliditas and Everest Medicines report Nefecon launch in China - Investing.com

Investing.com

Calliditas (CALT) Up as sNDA for Tarpeyo Gets Priority Review - MSN

MSN

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last? - Zacks Investment Research

Zacks Investment Research

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?

Zacks Investment Research

Positive NefIgArd open label extension results for Calliditas - The Pharma Letter

The Pharma Letter

Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug

Zacks Investment Research

CALT Stock Quote Price and Forecast - CNN

CNN

Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga

What's Going On With Vera Therapeutics Stock Today?

Benzinga

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday

Benzinga

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

It's time to take profits, says strategist with top S&P 500 target for next year

MarketWatch

Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

Benzinga

Aurinia (AUPH) Moves 5.7% Higher: Will This Strength Last? - Yahoo Movies UK

Yahoo Movies UK

Calliditas pulls out all the stops in bid to boost Tarpeyo uptake - The Pharma Letter

The Pharma Letter

Calliditas announces commercial availability of Tarpeyo in USA - The Pharma Letter

The Pharma Letter

Calliditas Therapeutics AB (publ) (CALT) Earnings Date and Reports 2024 - MarketBeat

MarketBeat

Calliditas Therapeutics AB (publ) (CALT) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

IPO Launch: Calliditas Therapeutics Seeks $75 Million In U.S. IPO - TheStreet

TheStreet

IPO Preview: Calliditas Therapeutics Starts U.S. IPO Effort - IPOs On TheStreet - U.S. IPO Research & Opinion - TheStreet

TheStreet